Graf Akcie XTNT (Xtant Medical Holdings, Inc.). Diskuze k akciím XTNT. Aktuální informace XTNT.

Základní informace o společnosti Xtant Medical Holdings, Inc. (Akcie XTNT)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace
Hodnota podniku (EV)
Tržby
EBITDA
Zisk
Růst v tržbách Q/Q %
Růst v tržbách Y/Y %
P/E (Cena vůči ziskům)
Forward P/E
EV/Sales
EV/EBITDA
EV/EBIT
PEG
Price/Sales
P/FCF
Price/Book
Účetní hodnota na akcii
Hotovost na akcii
FCF vůči ceně %
Počet zaměstnanců
Tržba na zaměstnance
Profit margin %
Operating margin %
Gross margin %
EBIT margin %
EBITDA margin %
EPS - Zisk na akcii
EPS - Kvartální růst %
EPS - Očekávaný růst příští rok %
Return on assets %
Return on equity %
ROIC %
ROCE %
Dluhy/Equity
Čistý dluh/EBITDA
Current ratio
Quick Ratio
Volatilita
Beta
RSI
Cílová cena analytiků
Známka akcie (dle analytiků)
Insider ownership %
Institutional ownership %
Počet akcií
Procento shortovaných akcií %
Short ratio %
Dividenda
Procentuální dividenda %
Dividenda/Zisk %
Obchodovaná od
Země

Finanční výsledky akcie XTNT

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$53.337$64.682$72.203$82.612$90.003$59.346
Cost Of Goods Sold$18.945$22.166$28.717$32.511$27.71$20.263
Gross Profit$34.392$42.516$43.486$50.101$62.293$39.083
Research And Development Expenses$0.657$0.932$1.702$2.441$3.411$2.546
SG&A Expenses$34.486$43.837$45.741$55.842$60.085$41.971
Other Operating Income Or Expenses--$-1.568$-1.901$-1.401$-2.591
Operating Expenses$54.088$66.935$132.281$120.446$97.548$71.424
Operating Income$-0.751$-2.253$-60.078$-37.834$-7.545$-12.078
Total Non-Operating Income/Expense$-5.976$-5.87$-10.021$-14.577$-11.898$-7.634
Pre-Tax Income$-6.727$-8.123$-70.099$-52.411$-19.443$-19.712
Income Taxes$0.296$0.098--$0.05$-17.537
Income After Taxes$-7.023$-8.221$-70.099$-52.411$-19.494$-2.174
Other Income------
Income From Continuous Operations$-7.023$-8.221$-70.099$-52.411$-19.494$-2.174
Income From Discontinued Operations------
Net Income$-7.023$-8.221$-70.099$-52.411$-19.494$-2.174
EBITDA$1.328$0.89$-53.488$-29.425$-0.303$-7.189
EBIT$-0.751$-2.253$-60.078$-37.834$-7.545$-12.078
Basic Shares Outstanding291312211
Shares Outstanding291312211
Basic EPS$-0.25$-0.63$-5.97$-34.76$-18.46$-2.88
EPS - Earnings Per Share$-0.25$-0.63$-5.97$-34.76$-18.46$-2.88
# 2020 2019 2018 2017 2016 2015
Current Ratio1.22293.43412.87751.53761.5742.0973
Long-term Debt / Capital-2.37972.27351.73481.06260.9258
Debt/Equity Ratio1.1587-1.7288-1.795-2.3672-18.484612.4724
Gross Margin64.480665.730860.227460.646269.21265.8565
Operating Margin-1.408-3.4832-83.2071-45.7972-8.3834-20.3521
EBIT Margin-1.408-3.4832-83.2071-45.7972-8.3834-20.3521
EBITDA Margin2.48981.376-74.08-35.6183-0.3371-12.1135
Pre-Tax Profit Margin-12.6123-12.5584-97.086-63.4424-21.6029-33.2153
Net Profit Margin-13.1672-12.7099-97.086-63.4424-21.6588-3.664
Asset Turnover1.28631.49881.55540.78150.62460.4208
Inventory Turnover Ratio0.88491.37671.65981.44991.0550.8932
Receiveable Turnover7.75256.3897.22756.49774.7393.8573
Days Sales In Receivables47.081857.129750.501456.173677.020394.6253
ROE - Return On Equity-48.387718.5974160.145789.2877275.5936-24.4964
Return On Tangible Equity-64.716217.1539147.421745.950423.0562.9829
ROA - Return On Assets-16.9368-19.0499-151.0038-49.5823-13.5276-1.5418
ROI - Return On Investment-48.3878-25.6594-203.9481-65.6064-17.2539-1.8188
Book Value Per Share0.1871-3.3585-3.3231-38.7452-4.92238.9562
Operating Cash Flow Per Share0.0058-0.13460.463313.2832-1.5792.7029
Free Cash Flow Per Share0.0013-0.14471.498417.7247-6.29692.5146